by Don McLean | Sep 12, 2019 | Blog
Planning for Health Canada’s New Transparency Initiatives for Clinical Data by Regina Parott In March 2019, Health Canada created a new transparency requirement. Health Canada’s Public Release of Clinical Information (PRCI) states that their “objective is to make...
by Don McLean | Sep 5, 2019 | Blog
Pharmaceutical Industry Experts Speak Out: Five Productivity Tips for Working from Home by Don F. McLean, MBA In the pharmaceutical industry, the right talent can often live in a variety of locations. When talking to our colleagues who have the privilege to work from...
by Don McLean | Aug 29, 2019 | Blog
Pharmaceutical Industry News Roundup: August 2019 by Staff Writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection of top stories to keep an eye on: Former FDA commissioners seek to expand use of RWE in regulatory...
by Don McLean | Aug 22, 2019 | Blog
Using Real World Data in Drug Development: Five Questions with Vijay Ivaturi by Staff Writer The idea and practice of using real world data in the pharmaceutical industry has driven much conversation as of late. As groups like the Health Analytics Collective begin to...
by Don McLean | Aug 15, 2019 | Blog
Recommended Reading from Eight Pharmaceutical Experts This Summer by Staff Writer Summer reading isn’t reserved for school-aged children, as adults and professionals alike can gain knowledge and insights from consistently reading material during the hottest months of...
by Don McLean | Jul 25, 2019 | Blog
Pharmaceutical Industry News Roundup: July 2019 by Staff writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection of top stories to keep an eye on: Score: Data-sharing practices improve after public...
